| Time | Events or Topics | Speakers |
MONDAY OCTOBER 13th |
14:00-17:00 | Registration |
17:00 | Welcome and opening remarks |
17:15 | Normal and neoplastic stem cells | Keynote Speaker |
Irving L. WEISSMAN,Stanford University,US A. |
18:15-19:45 | Reception and Poster Session |
TUESDAY OCTOBER 14th |
8:00-9:00 | Registration |
9:00-10:40 | Session I: Cell Fate Choices and Reprogramming |
| Novel strategies for cellular reprogramming | Hongkui DENG, Peking University, China |
| Human cellular models of CNS disease and evolution | Fred H. GAGE,Salk Institute, USA |
| Somatic reprogramming and embryonic development | Jinsong LI,Shanghai Institute for Biological Sciences, Chinese Academy of Science, China |
| In vivo generation of functional cells and organs from iPSCs | Hiromitsu NAKAUCHI, University of Tokyo, Japan |
10:40-11:10 | Coffee Break |
11:10-12:50 | Session II: Animal models |
| Basic research and potential application of stem cells: Cell banks and animal models | Qi ZHOU, Institute of Zoology, Chinese Academy of Science, China |
| Pig as a model system for stem cell research | Ning LI, China Agricultural University, China |
| Modeling neurological disorders with iPSC technologies and transgenic non-human primates | Hideyuki OKANO, Keio University, Japan |
| Gene targeting in monkeys with TALEN and CRISPR/Cas9 | Weizhi JI, Kunming Institute of Zoology, Chinese Academy of Sciences, China |
12:50-14:00 | Lunch |
14:00 – 15:40 | Session III: Organs and Regeneration |
| Translating stem cells to the treatment of life-threatening liver disease | Ira J.FOX, University of Pittsburgh, USA |
| Engineering pluripotent stem cell
microenvironments for directed morphogenesis | Todd McDEVITT, Georgia Institute of Technology,, USA |
| Making pancreatic beta cells from stem cells | Maike SANDER，University of California, San Diego, USA |
| Immune regulation of tissue regeneration | Nadia ROSENTHAL, Imperial College, London, UK |
15:40-16:00 | Coffee Break |
16:00-17:30 | Session IV: Panel Discussion: International Guidelines for Stem Cell Therapies |
| Fred H. GAGE, Qi ZHOU, Irv L. WEISSMAN, Christine L. MUMMERY,Nadia ROSENTHAL |
WEDNESDAY OCTOBER 15th |
9:00-10:00 | Human pluripotent stem cells as models of cardiovascular disease | Keynote Speaker |
Christine L. MUMMERY, Leiden University Medical Centre, ?the Netherlands |
10:00-10:30 | Coffee Break |
10:30-12:10 | Session V: Translational and Clinical Applications |
| Early clinical trial results in spinal cord injury and age-related macular degeneration | Ann TSUKAMOTO, Stem Cells Inc.USA. |
| Stem cell therapy for human neurodegenerative disorders--how can we make it work ? | Olle LINDVALL, University of Lund, Sweden. |
| A big Pharma perspective on cell therapies | Mark ZIMMERMAN，Johnson and Johnson, USA |
| Creating health and wealth through cell therapy translation | Keith THOMPSON, Catapult (UK) |
12:10-13:20 | Lunch |
13:20 -15:00 | Session VI: New Tools and Techniques |
| Development and applications of CRISPR-Cas9 for genome biology | Feng ZHANG, Broad Institute of MIT and Harvard, USA |
| Tissue mechanics from a stem cell perspective | Dennis E. DISCHER, University of Pennsylvania, USA |
| The biomechanics of tissue architecture and plasticity: Concepts and tools | Thomas LECUIT, Developmental Biology Institute of Marseille (IBDM), France |
| Long-term single stem cell quantification: New tools for old questions | Timm SCHROEDER, ETH Zurich, Switzerland |
15:00-15:15 | Coffee Break |
15:15-16:30 | Session VII: Panel Discussion: Translational Obstacles to Stem Cell Therapy Implementation
Chair: Mark ZIMMERMAN |
| Mark ZIMMERMAN, Keith THOMPSON,Ira J. FOX, Ann TSUKAMOTO. |
16:30 | Closing Remarks |
